Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s oncology formulation manufacturing facility at Duvvada at Visakhapatnam, Andhra Pradesh. ...
Here is a quick summary of the third quarter financial results for all the companies announced till date. For some companies, management comments have been ...
Effective January 9th 2017, the US Food and Drug Administration (FDA) has announced an amendment to the final rule ((the rule governs the manner in which FDA ...
The big boy of the pharma sector, Dr. Reddys Laboratories has come out with its Q1 results for 2016. The results have not been taken well by investors and the ...
Q4 Results are out! As the Nifty 50 companies line up to disclose their performance report, we bring you a summary of their results along with the schedule ...
Q4 Results are out! As the companies line up to disclose their performance report, we bring you a daily summary of the previous days results. Here is a quick ...
This is our follow-on newsletter w.r.t the Warning Letters issued by the US FDA to Dr. Reddy’s Laboratories on 6-Nov-15. Let us do a quick recap of what ...
Dr. Reddy’s Lab tanked on Friday and then again today, after news came out that involved US action against the company. The stock has been in news for 2 ...
